• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较姜黄素和熊去氧胆酸对乙醇诱导的大鼠肝损伤的保护作用。

Comparing the Protective Effects of Curcumin and Ursodeoxycholic Acid after Ethanol-Induced Hepatotoxicity in Rat Liver.

机构信息

Department of Biology, Kazerun Branch, Islamic Azad University, Kazerun, Iran.

出版信息

Ethiop J Health Sci. 2021 May;31(3):673-682. doi: 10.4314/ejhs.v31i3.25.

DOI:10.4314/ejhs.v31i3.25
PMID:34483625
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8365490/
Abstract

BACKGROUND

Alcohol consumption can cause hepatitis and long-term cirrhosis of the liver. The aim of this study was to evaluate the protective effects of curcumin (CUR) and ursodeoxycholic acid (UDCA) alone and together in the prevention and treatment of liver damage caused by overuse of ethanol.

METHODS

Adult Wistar rats were divided into 8 groups of 5, including the control group and various combinations of ethanol, CUR and UDCA groups. Twenty-eight days after the oral treatment, serum levels of aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT) and Arginase I (ArgI) as well as serum levels of Albumin (Alb), total protein (TP) and Blood Urea Nitrogen (BUN) were measured, and liver tissue was evaluated histopathologically.

RESULTS

The solo administration of CUR, UDCA and CUR+UDCA had no effect on the blood parameters and liver tissue compared to the control group (p>0.05). The solo administration of CUR and UDCA in ethanol-treated rats significantly reduced ALT, AST, ALP, GGT, ArgI and BUN levels (p<0.05), while the solo administration increased Alb and TP levels compared to the ethanol group (p<0.05). In these groups, a significant decrease in cell necrosis and local inflammation of hepatocytes was observed, and the liver damage was mild. However, co-administration of ethanol, CUR and UDCA made significantly greater decrease in ALT, AST, ALP, GGT, ArgI and BUN levels (p>0.05), while the co-administration greatly increased Alb and TP levels compared to the ethanol group (p<0.05). Histopathologically, a decrease in structural changes in liver tissue and inflammation was observed, resulting in the improvement of liver tissue.

CONCLUSION

The solo administration of CUR and UDCA could reduce ethanol-induced liver damage in rats and improve liver's serum and blood parameters. However, the coadministration of CUR and UDCA has a greater efficacy.

摘要

背景

饮酒可导致肝炎和长期肝硬化。本研究旨在评估姜黄素(CUR)和熊去氧胆酸(UDCA)单独及联合应用于预防和治疗乙醇过度使用引起的肝损伤的保护作用。

方法

将成年 Wistar 大鼠分为 8 组,每组 5 只,包括对照组和乙醇、CUR 和 UDCA 各组合组。口服治疗 28 天后,测定血清天门冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、碱性磷酸酶(ALP)、γ-谷氨酰转移酶(GGT)和精氨酸酶 I(ArgI)以及血清白蛋白(Alb)、总蛋白(TP)和血尿素氮(BUN)水平,并进行肝组织病理评估。

结果

与对照组相比,CUR、UDCA 单独给药以及 CUR+UDCA 单独给药对血液参数和肝组织均无影响(p>0.05)。在乙醇处理的大鼠中,CUR 和 UDCA 单独给药可显著降低 ALT、AST、ALP、GGT、ArgI 和 BUN 水平(p<0.05),同时与乙醇组相比,CUR 和 UDCA 单独给药可提高 Alb 和 TP 水平(p<0.05)。在这些组中,观察到肝细胞坏死和局部炎症明显减少,肝损伤较轻。然而,与乙醇组相比,乙醇、CUR 和 UDCA 联合给药使 ALT、AST、ALP、GGT、ArgI 和 BUN 水平显著降低(p>0.05),同时 Alb 和 TP 水平显著升高(p<0.05)。组织病理学检查显示,肝组织结构变化和炎症减轻,肝组织得到改善。

结论

CUR 和 UDCA 单独给药可减轻乙醇诱导的大鼠肝损伤,改善肝脏的血清和血液参数。然而,CUR 和 UDCA 的联合给药具有更大的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d272/8365490/eec0edc82e5f/EJHS3103-0673Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d272/8365490/9405f80cf2df/EJHS3103-0673Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d272/8365490/eec0edc82e5f/EJHS3103-0673Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d272/8365490/9405f80cf2df/EJHS3103-0673Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d272/8365490/eec0edc82e5f/EJHS3103-0673Fig2.jpg

相似文献

1
Comparing the Protective Effects of Curcumin and Ursodeoxycholic Acid after Ethanol-Induced Hepatotoxicity in Rat Liver.比较姜黄素和熊去氧胆酸对乙醇诱导的大鼠肝损伤的保护作用。
Ethiop J Health Sci. 2021 May;31(3):673-682. doi: 10.4314/ejhs.v31i3.25.
2
Evaluation of Nano-curcumin effects against Tartrazine-induced abnormalities in liver and kidney histology and other biochemical parameters.评估纳米姜黄素对柠檬黄诱导的肝脏和肾脏组织学异常及其他生化参数的影响。
Food Sci Nutr. 2022 Mar 21;10(5):1344-1356. doi: 10.1002/fsn3.2790. eCollection 2022 May.
3
Role of ursodeoxycholic acid in prevention of methotrexate-induced liver toxicity.熊去氧胆酸在预防甲氨蝶呤所致肝毒性中的作用。
Dig Dis Sci. 2008 Apr;53(4):1071-7. doi: 10.1007/s10620-007-9949-3. Epub 2007 Oct 13.
4
Role of ursodeoxycholic acid in prevention of hepatotoxicity caused by amoxicillin-clavulanic acid in rats.熊去氧胆酸在预防大鼠阿莫西林-克拉维酸所致肝毒性中的作用。
Ann Hepatol. 2009 Apr-Jun;8(2):134-40.
5
Nanocurcumin Improves Lipid Status, Oxidative Stress, and Function of the Liver in Aluminium Phosphide-Induced Toxicity: Cellular and Molecular Mechanisms.纳米姜黄素改善磷化铝诱导毒性的脂质状态、氧化应激和肝脏功能:细胞和分子机制。
Biomed Res Int. 2022 Sep 12;2022:7659765. doi: 10.1155/2022/7659765. eCollection 2022.
6
Hepatoprotective effect of Stachys pilifera ethanol extract in carbon tetrachloride-induce hepatotoxicity in rats.水苏乙醇提取物对四氯化碳诱导的大鼠肝毒性的肝保护作用。
Pharm Biol. 2017 Dec;55(1):1389-1393. doi: 10.1080/13880209.2017.1302484.
7
Pharmacological Evaluation of Hepatoprotective Activity of AHPL/AYTAB/0613 Tablet in Carbon Tetrachloride-, Ethanol-, and Paracetamol-Induced Hepatotoxicity Models in Wistar Albino Rats.AHPL/AYTAB/0613片对Wistar白化大鼠四氯化碳、乙醇和对乙酰氨基酚诱导的肝毒性模型的肝保护活性的药理学评价。
Pharmacognosy Res. 2017 Dec;9(Suppl 1):S41-S47. doi: 10.4103/pr.pr_44_17.
8
Curcumin Attenuates Hepatotoxicity Induced by Zinc Oxide Nanoparticles in Rats.姜黄素减轻氧化锌纳米颗粒诱导的大鼠肝毒性。
Balkan Med J. 2016 May;33(3):252-7. doi: 10.5152/balkanmedj.2016.150017. Epub 2016 May 1.
9
Effects of antioxidant agents against cyclosporine-induced hepatotoxicity.抗氧化剂对环孢素诱导的肝毒性的影响。
J Surg Res. 2015 Feb;193(2):658-66. doi: 10.1016/j.jss.2014.08.042. Epub 2014 Sep 1.
10
Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.乙炔雌二醇诱导的胆汁淤积中胆小管膜酶的胆汁排泄增强。熊去氧胆酸给药的影响。
Biochem Pharmacol. 1995 Oct 12;50(8):1223-32. doi: 10.1016/0006-2952(95)00262-x.

引用本文的文献

1
Alcohol-induced liver injury in signalling pathways and curcumin's therapeutic potential.酒精诱导的肝脏损伤的信号通路及姜黄素的治疗潜力
Toxicol Rep. 2023 Oct 12;11:355-367. doi: 10.1016/j.toxrep.2023.10.005. eCollection 2023 Dec.
2
Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy.慢性肝病中的抗氧化剂和抗炎剂:分子机制与治疗
World J Hepatol. 2023 Feb 27;15(2):180-200. doi: 10.4254/wjh.v15.i2.180.
3
The Status of Oxidative Stress in Patients with Alcohol Dependence: A Meta-Analysis.

本文引用的文献

1
Chronic treatment of curcumin improves hepatic lipid metabolism and alleviates the renal damage in adenine-induced chronic kidney disease in Sprague-Dawley rats.姜黄素的慢性治疗可改善肝脂代谢,减轻腺嘌呤诱导的 Sprague-Dawley 大鼠慢性肾脏病的肾脏损伤。
BMC Nephrol. 2019 Nov 21;20(1):431. doi: 10.1186/s12882-019-1621-6.
2
Histologic Findings of Advanced Fibrosis and Cirrhosis in Patients With Nonalcoholic Fatty Liver Disease Who Have Normal Aminotransferase Levels.非酒精性脂肪性肝病患者转氨酶水平正常时的晚期纤维化和肝硬化的组织学发现。
Am J Gastroenterol. 2019 Oct;114(10):1626-1635. doi: 10.14309/ajg.0000000000000388.
3
酒精依赖患者氧化应激状态的Meta分析
Antioxidants (Basel). 2022 Sep 28;11(10):1919. doi: 10.3390/antiox11101919.
Alcoholic Liver Disease: Current Mechanistic Aspects with Focus on Their Clinical Relevance.
酒精性肝病:当前的机制研究进展及其临床相关性
Biomedicines. 2019 Sep 5;7(3):68. doi: 10.3390/biomedicines7030068.
4
Deranged hepatocyte intracellular Ca homeostasis and the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma.肝细胞内 Ca 稳态紊乱与非酒精性脂肪性肝病向肝细胞癌的进展。
Cell Calcium. 2019 Sep;82:102057. doi: 10.1016/j.ceca.2019.102057. Epub 2019 Jul 26.
5
Hepatoprotective Effect of Melatonin in Toxic Liver Injury in Rats.褪黑素对大鼠中毒性肝损伤的保护作用。
Medicina (Kaunas). 2019 Jun 24;55(6):304. doi: 10.3390/medicina55060304.
6
Acute Liver Failure due to Wilson Disease: Eight Years of the National Liver Transplant Program in Uruguay.Wilson 病致急性肝衰竭:乌拉圭国家肝移植项目 8 年经验。
Ann Hepatol. 2019 Jan-Feb;18(1):187-192. doi: 10.5604/01.3001.0012.7911.
7
Therapeutic effects of curcumin and ursodexycholic acid on non-alcoholic fatty liver disease.姜黄素和熊去氧胆酸对非酒精性脂肪性肝病的治疗作用。
Biomed Pharmacother. 2019 Jul;115:108938. doi: 10.1016/j.biopha.2019.108938. Epub 2019 May 6.
8
Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathways.熊去氧胆酸通过调节氨基酸、黄酮类化合物和脂肪酸代谢途径发挥保肝作用。
Metabolomics. 2019 Feb 27;15(3):30. doi: 10.1007/s11306-019-1494-5.
9
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction.熊去氧胆酸通过苯丙氨酸/酪氨酸途径和肝功能障碍患者的微生物组重塑改善肝功能。
Sci Rep. 2018 Aug 8;8(1):11874. doi: 10.1038/s41598-018-30349-1.
10
Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective.姜黄素在肝脏疾病中的作用:氧化应激的细胞机制系统评价及临床展望。
Nutrients. 2018 Jul 1;10(7):855. doi: 10.3390/nu10070855.